Wednesday, March 07, 2007 6:53:19 PM
I found this newsletter article entitled “EntreMed's Panzem enters liver cancer study---Marketletter - Mar. 12, 2007 “
However the article is only about the announced renal cancer study. I hope the proof reader is a fortune teller and not a surgeon.
Aaron
http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1264271&contentType=sentryarticle...
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM